Welcome to
EndoCyclic Therapeutics

Developing the first non-hormonal therapeutic for endometriosis

Endometriosis has been considered the greatest overlooked epidemic in women’s health.  At least 10% of girls and women worldwide have endometriosis, affecting all ethnicities alike. It is the leading cause of female infertility, chronic pelvic pain, and gynecologic surgeries.  

Shockingly, to date, there is no cure for endometriosis. The current management protocols include hormone and pain therapies which still fail to reverse the disease or address the root cause. Patients must often resort to surgery, leaving the possibility for reoccurrence.

As the number one cause of disability in women in their reproductive years, endometriosis is currently affecting over 176 million women worldwide and their ability to work, parent, or simply enjoy life.

Why It Matters

Stressed Woman
 

Our Approach

 
bullseye-outline.png

Straight to the Cause

EndoCyclic Therapeutics is developing a treatment for endometriosis that addresses the root cause of the disease. We aim to give women afflicted by endometriosis the chance to finally enjoy remission from this painful disease.

Molecule

Groundbreaking Therapeutics

We are developing revolutionary molecules that can invade endometriosis disease cells at the source. These molecules are “first-in-class” and bind to directly to non-hormonal targets.  

Thorough Research Methodology

We have discovered a new biochemical pathway that triggers endometriosis. We are designing novel targeted therapeutics that disrupt disease initiation without the use of hormones.

 

Helping Women Live
Pain-Free Lives

At EndoCyclic Therapeutics, our mission is to stop the suffering of millions of women - and their families - who are affected by endometriosis. 

 

Our team includes the top talent from medicine, biology, chemistry, bioinformatics, and engineering who have come together to focus their energies on this serious women health issue.  Our goal is to liberate millions of women from the pain and infertility caused by endometriosis.

 
 

News

NICHD.png

ENDOMETRIOSIS RESEARCH TO DEVELOP NON-INVASIVE TREATMENT AND DIAGNOSIS

"The company’s lab, supported by an NICHD small business grant, is cultivating tiny molecules that invade and kill endometrial cells at the source, stopping them from spreading and growing painful lesions."

endofound_logo_square_edited.jpg

THE RESEARCHERS AT THE FOREFRONT OF NON-INVASIVE ENDOMETRIOSIS TREATMENT

"What’s also exciting about EndoCyclic’s molecular approach is that they’ve identified several different molecules that could work at different stages of the disease. "

9WCPO.jpg

UC SCIENTIST WORKING TO FIND A CURE FOR ENDOMETRIOSIS

“Our hope, really, at the end of the day, is to help young women become older women who don’t have to live their life in pain”

1200px-The_University_of_California_UCLA.svg.png

ALUMNA CREATES COMPANY TO DEVELOP NONHORMONAL ENDOMETRIOSIS TREATMENT

“I like to say that endometriosis attacked the wrong girl, because we’re fighting back,” Petrossian said. “A disease that attacks 10 percent of our girls and women worldwide attacks all of us, so let’s wipe it out.”

Daily Bruin.PNG

TANYA PETROSSIAN DISCUSSES ENDOMETRIOSIS

Dr. Petrossian is fighting against an overlooked epidemic that affects more than 10 percent of girls and women worldwide.

Get Involved

Whether you are a patient, physician, advocate, academic, investor, or potential industry partner, we want to hear from you. Contact us to see how you can get involved.

Business Development: bd@endocyclictherapeutics.com

Address: 5270 California Ave, Suite 300 Irvine, CA 92617

Your details were sent successfully!

 
 

EndoMet Biosciences, Inc. ©2021  | Terms of Use

  • LinkedIn - Grey Circle